Allogene Therapeutics recently released exciting results ... such as accepting the 'non-self', and graft versus-host disease. That's why the 7th Annual Allogeneic Cell Therapies Summit is your ...

According to BioXcel Therapeutics, Inc. (NASDAQ:BTAI), it aims to enroll 200 patients to join the study, and it officially ...

Armata is a clinical-stage biotechnology company focused on the development of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat ...

We use cookies to ensure that we give you the best experience on our website. You can change your cookies in your browser at any time.

CAMBRIDGE, Mass. & MONTREAL — Repare Therapeutics Inc. (“Repare” or the “Company”) (Nasdaq: RPTX), a clinical-stage precision oncology company, today reported financial results for the fourth quarter ...

Centauri Therapeutics Limited has announced the selection of its first clinical candidate for the ABX-01 programme. The compound is designed to target serious Gram-negative bacterial lung infections.

Cadrenal Therapeutics, Inc. (Nasdaq ... and provided a business update and highlights of the path forward for the clinical advancement of tecarfarin. “2024 for Cadrenal was a year of focus ...

CERo Therapeutics Holdings, Inc. is advancing its position in the immunotherapy sector as it prepares for the launch of its Phase 1 clinical trial for Acute Myeloid Leukemia (AML). The company has ...

and we remain confident that our lead candidate will continue to demonstrate this as we progress towards a Phase I clinical trial,” commented Dr Jennifer Schneider, CEO, Centauri Therapeutics.

BETHESDA, Md., March 14, 2025 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) ("Gain”, or the "Company”), a clinical-stage biotechnology company leading the discovery and development of the ...

we believe that Callio Therapeutics will be the first company to show the clinical benefit of this exciting new multi-payload ADC approach and is well positioned to transform cancer therapy.” ...